Howell L L, Byrd L D
Yerkes Regional Primate Research Center, Emory University, Atlanta, Georgia.
J Pharmacol Exp Ther. 1993 Oct;267(1):432-9.
The behavioral effects of CGS 15943 (0.1-3.0 mg/kg), a nonxanthine adenosine antagonist lacking phosphodiesterase (PDE) inhibitory effects, and caffeine (1.0-30.0 mg/kg), a xanthine adenosine antagonist with PDE inhibitory effects, were compared in squirrel monkeys trained to lever-press under fixed interval (FI) schedules of food presentation or stimulus termination. Both adenosine antagonists increased FI response rates after i.m. or i.v. administration, with CGS 15943 being more efficacious and approximately 3 to 10 times more potent than caffeine. Moreover, the rate-increasing effects of caffeine were enhanced by CGS 15943 (0.3 and 1.0 mg/kg) pretreatment. In contrast, rolipram (0.01-0.1 mg/kg), a potent PDE inhibitor lacking adenosine-antagonist effects, only decreased response rates. The nonselective adenosine agonist, 5'-N-ethylcarboxamidadenosine (0.003-0.03 mg/kg), the A1-selective adenosine agonists, N6-cyclopentyladenosine (0.1-1.0 mg/kg) and N6-cyclohexyladenosine (0.1-1.0 mg/kg) and the A2-selective adenosine agonist, CGS 21680 (0.03-0.3 mg/kg), produced dose-dependent decreases in response rates that were attenuated by CGS 15943 and caffeine. The potency difference between CGS 15943 and caffeine as antagonists of 5'-N-ethylcarboxamidadenosine, N6-cyclopentyladenosine and N6-cyclohexyladenosine corresponded to the potency difference of the two drugs for increasing FI response rates. In contrast, CGS 15943 and caffeine were approximately equipotent as antagonists of CGS 21680. The similarity of the effects of CGS 15943 and caffeine supports and extends previous findings suggesting that the behavioral-stimulant effects of caffeine and other xanthines are mediated through adenosine-antagonist actions rather than inhibition of PDE activity.
在接受训练、能在固定间隔(FI)的食物呈现或刺激终止时间表下进行杠杆按压的松鼠猴中,比较了CGS 15943(0.1 - 3.0毫克/千克)和咖啡因(1.0 - 30.0毫克/千克)的行为效应。CGS 15943是一种缺乏磷酸二酯酶(PDE)抑制作用的非黄嘌呤腺苷拮抗剂,咖啡因是一种具有PDE抑制作用的黄嘌呤腺苷拮抗剂。两种腺苷拮抗剂在肌肉注射或静脉注射后均提高了FI反应率,CGS 15943更有效,其效力比咖啡因高约3至10倍。此外,CGS 15943(0.3和1.0毫克/千克)预处理增强了咖啡因的速率增加效应。相比之下,咯利普兰(0.01 - 0.1毫克/千克)是一种缺乏腺苷拮抗剂作用的强效PDE抑制剂,仅降低反应率。非选择性腺苷激动剂5'-N-乙基甲酰胺腺苷(0.003 - 0.03毫克/千克)、A1选择性腺苷激动剂N6-环戊基腺苷(0.1 - 1.0毫克/千克)和N6-环己基腺苷(0.1 - 1.0毫克/千克)以及A2选择性腺苷激动剂CGS 21680(0.03 - 0.3毫克/千克)产生剂量依赖性的反应率降低,而CGS 15943和咖啡因可减弱这种降低。CGS 15943和咖啡因作为5'-N-乙基甲酰胺腺苷、N6-环戊基腺苷和N6-环己基腺苷拮抗剂的效力差异与这两种药物提高FI反应率的效力差异相对应。相比之下,CGS 15943和咖啡因作为CGS 21680的拮抗剂效力大致相当。CGS 15943和咖啡因作用的相似性支持并扩展了先前的研究结果,表明咖啡因和其他黄嘌呤的行为刺激作用是通过腺苷拮抗作用介导的,而非通过抑制PDE活性。